Innoviva (INVA) Invested Capital (2009 - 2026)
Innoviva posted quarterly Invested Capital of $1.3 billion for Q1 2026, up 59.89% year-on-year from $839.1 million in Q1 2025, and up 14.39% on a QoQ basis from $1.2 billion in Q4 2025.
Innoviva (INVA) has 18 years of Invested Capital data on file, last reported at $1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 59.89% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 59.89% YoY), and the FY2025 full-year result was $1.2 billion, up 23.79% from the prior year.
- Invested Capital for Q1 2026 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.3 billion in Q1 2026 and bottomed at $555.1 million in Q2 2023.
- The 5-year median for Invested Capital is $737.5 million (2022), against an average of $813.6 million.
- The widest annual swing landed in 2022, when Invested Capital sank 31.0%; it then surged 59.89% in 2026.
- A 5-year view of Invested Capital shows it stood at $662.0 million in 2022, then jumped by 40.47% to $929.9 million in 2023, then climbed by 1.89% to $947.5 million in 2024, then climbed by 23.79% to $1.2 billion in 2025, then climbed by 14.39% to $1.3 billion in 2026.
- The last three Invested Capital figures came in at $1.3 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 906.72 Mn |
| Mar 31, 2025 | 839.12 Mn |
| Dec 31, 2024 | 947.48 Mn |
| Sep 30, 2024 | 860.39 Mn |
| Jun 30, 2024 | 665.52 Mn |
| Mar 31, 2024 | 703.68 Mn |
| Dec 31, 2023 | 929.89 Mn |
| Sep 30, 2023 | 627.49 Mn |
| Jun 30, 2023 | 555.09 Mn |
| Mar 31, 2023 | 561.49 Mn |
| Dec 31, 2022 | 661.98 Mn |
| Sep 30, 2022 | 737.50 Mn |
| Jun 30, 2022 | 661.53 Mn |
| Mar 31, 2022 | 648.23 Mn |
| Dec 31, 2021 | 959.42 Mn |
| Sep 30, 2021 | 491.81 Mn |
| Jun 30, 2021 | 827.23 Mn |
| Mar 31, 2021 | 696.68 Mn |
| Dec 31, 2020 | 1.04 Bn |
| Sep 30, 2020 | 534.87 Mn |
| Jun 30, 2020 | 492.81 Mn |
| Mar 31, 2020 | 405.87 Mn |
| Dec 31, 2019 | 342.12 Mn |
| Sep 30, 2019 | 731.00 Mn |
| Jun 30, 2019 | 246.70 Mn |
| Mar 31, 2019 | 199.94 Mn |
| Dec 31, 2018 | 606.29 Mn |
| Sep 30, 2018 | -108.28 Mn |
| Jun 30, 2018 | -155.36 Mn |
| Mar 31, 2018 | -212.75 Mn |
| Dec 31, 2017 | -217.71 Mn |
| Sep 30, 2017 | -197.96 Mn |
| Jun 30, 2017 | -281.55 Mn |
| Mar 31, 2017 | -327.48 Mn |
| Dec 31, 2016 | -345.24 Mn |
| Sep 30, 2016 | -364.31 Mn |
| Jun 30, 2016 | -359.84 Mn |
| Mar 31, 2016 | -361.97 Mn |
| Dec 31, 2015 | -342.65 Mn |
| Sep 30, 2015 | -323.00 Mn |
| Jun 30, 2015 | -293.99 Mn |
| Mar 31, 2015 | -260.14 Mn |
| Dec 31, 2014 | 502.29 Mn |
| Sep 30, 2014 | -183.14 Mn |
| Jun 30, 2014 | 315.98 Mn |
| Mar 31, 2014 | 263.25 Mn |
| Dec 31, 2013 | 586.62 Mn |
| Sep 30, 2013 | 330.05 Mn |
| Jun 30, 2013 | 85.65 Mn |
| Mar 31, 2013 | 91.51 Mn |
| Dec 31, 2012 | 155.03 Mn |
| Sep 30, 2012 | 173.29 Mn |
| Jun 30, 2012 | 189.26 Mn |
| Mar 31, 2012 | 6.14 Mn |
| Dec 31, 2011 | -86.98 Mn |
| Sep 30, 2011 | -59.04 Mn |
| Jun 30, 2011 | -37.32 Mn |
| Dec 31, 2010 | -22.21 Mn |
| Dec 31, 2009 | -188.99 Mn |